Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors. - Wikidata - wikimedia - TriplyDB

Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors.

Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors.

http://www.wikidata.org/entity/Q36926013

about

Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia.Nanoparticle-based drug delivery systems: What can they really do in vivo?Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment.Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles.Reengineering red blood cells for cellular therapeutics and diagnostics.Cell membrane-derived nanomaterials for biomedical applications.Bio-inspired nanomedicine strategies for artificial blood components.Biomimetic and bioinspired nanoparticles for targeted drug delivery.Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy.Remote Loading of Small-Molecule Therapeutics into Cholesterol-Enriched Cell-Membrane-Derived Vesicles.Cell membrane coated nanoparticles: next-generation therapeutics.Inflammation and Cancer: In Medio Stat Nano.Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles.Cell Membrane Coating Nanotechnology.Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy.Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment.Remote-Loaded Platelet Vesicles for Disease-Targeted Delivery of Therapeutics Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment

P2860

Q33435943-2F71D2C0-7225-41D7-B0BA-883F7BFEB452 Q33772186-BA3F0ADA-4958-4CCA-BE23-7AC291B849FC Q38712865-E07F71BF-BDA9-43FA-A609-C54F75568CE2 Q38734878-22C10CC3-1551-4CFC-8BC7-6D6DA06BC3BA Q39100275-839EBDCA-CB91-4F64-A026-E75E5AEF3BB1 Q39178313-1C5A2848-D8E1-4CAA-B47D-929BF4012355 Q39179984-8C3B0FB2-BFF1-4C6D-A6BF-94FA94CF432C Q39210548-8E1B2F67-5A9B-4C44-A865-69D875C89473 Q41430285-9FC91DD8-FCE0-43C9-B6D4-6F230DC1979B Q46399483-3182E0F8-459C-4CB4-8B6D-9894F173F256 Q47613637-B3ECA8DC-7F7E-4FB4-8D55-5AD35BFA4829 Q47877048-84B1F2AA-6B87-41A5-B942-53F4F1F265D3 Q48116102-EC7A6887-FD3A-4B62-AFE9-FE61F03512C1 Q52628718-5313BEF8-C0A4-4217-B4D1-686C9CCD4312 Q52647664-3578BB72-7F10-4E02-9A6A-92FFE07A4966 Q55222537-165667D5-5575-49A7-AA1B-2D21C94F72B0 Q57497316-19F77671-4EF0-48DC-8B48-1B4D1F7E4383 Q58781545-02C086B3-3DA8-4748-81B1-69B7A0B79D28

P2860

Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors.

http://www.wikidata.org/entity/Q36926013

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Safe and Immunocompatible Nano ...... elivery to Treat Solid Tumors.

@en

type

label

Safe and Immunocompatible Nano ...... elivery to Treat Solid Tumors.

@en

prefLabel

Safe and Immunocompatible Nano ...... elivery to Treat Solid Tumors.

@en

P1433

Q36926013-7553B435-1A2E-4F8F-9C5E-454274583BDC

P1476

Q36926013-A4955EEE-3D00-4384-A8A0-ACE86673FB3F

P2093

Q36926013-03666D7C-D7E1-42FE-9B89-2A3B337F8A1C

Q36926013-0D03F354-09F3-49C0-B656-3F13BC832327

Q36926013-40859D02-9D80-4CC0-B758-C5378B56CCE2

Q36926013-4699800B-1A7A-4D88-A250-268003C183CF

Q36926013-4A80F4C3-126D-40C0-80DA-044E10C74B0E

Q36926013-4AB9801D-8987-4345-BAE6-A5BF3AE6F0FF

Q36926013-79AB573A-30AE-4044-A00F-272A554F2ED5

Q36926013-7B33EFBB-178D-45F8-9A5B-42BAC78F14E2

Q36926013-921E6DEF-0489-4CFC-93F1-20836A6D5C0C

Q36926013-DBF4A0B1-4E67-440C-8B45-34E293A4E3E2

P2860

Q36926013-1674D040-4178-4F6A-AFA0-2C2B3671D68F

Q36926013-1E17243B-11E7-495B-85E4-1CAB1FDCC8E2

Q36926013-1F68823B-3138-4F24-B8F5-0E1BF98DB539

Q36926013-20E273D2-D602-4235-880E-E33F36BFDD8A

Q36926013-20EB4E70-0C9F-409E-809A-1BB3671A25C5

Q36926013-2653B6BD-751A-4429-83C7-6433036F2BDC

Q36926013-298A3EBD-3027-4254-99A9-C2D55A4F6FBD

Q36926013-2B87BF6D-EAD7-4F6C-A85D-DD0ADB00589A

Q36926013-2F19F51F-12F0-40CB-937E-AEAF766998D2

Q36926013-320C479F-81EF-4635-B130-81B6A048D3CB

P304

Q36926013-A9F3E79E-7841-46E9-AF3F-A4CB9161C700

P31

Q36926013-DBC71C11-B46A-4751-BC59-7FFFA928794F

P356

Q36926013-8783A2A5-4288-4516-976B-D1285B014FFF

P433

Q36926013-14AE6A17-FD93-44AD-8C36-5FCD3565F252

P478

Q36926013-01A1B8D9-149D-46AA-B303-B5D555626396

P577

Q36926013-A82F3ECB-347F-4DEC-959C-90B0D37995FC

P698

Q36926013-8FFB3693-14BF-4D5F-953E-32CE8017CC6D

P921

Q36926013-1260B65E-C881-4F74-8ABD-F734A1E69370

Q36926013-C25D8E67-6FBB-4785-94C9-48CF22CF1AB5

P932

Q36926013-0F6FB914-998B-4CE9-9687-C8231FEF3A59

P356

P1433

P1476

Safe and Immunocompatible Nano ...... elivery to Treat Solid Tumors.

@en

P2093

Brian T Luk

http://www.w3.org/2001/XMLSchema#string

Che-Ming J Hu

http://www.w3.org/2001/XMLSchema#string

Diana Dehaini

http://www.w3.org/2001/XMLSchema#string

Jonathan A Copp

http://www.w3.org/2001/XMLSchema#string

Kang Zhang

http://www.w3.org/2001/XMLSchema#string

Liangfang Zhang

http://www.w3.org/2001/XMLSchema#string

Ronnie H Fang

http://www.w3.org/2001/XMLSchema#string

Shulin Li

http://www.w3.org/2001/XMLSchema#string

Soracha Thamphiwatana

http://www.w3.org/2001/XMLSchema#string

Weiwei Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

Drug delivery and nanoparticles:applications and hazards

Role of CD47 as a marker of self on red blood cells

Macromolecular therapeutics in cancer treatment: the EPR effect and beyond

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

Nanoparticle therapeutics: an emerging treatment modality for cancer

Nanocarriers as an emerging platform for cancer therapy

Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions

Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction

Current strategies for managing myelosuppression in patients with cancer.

P304

1004-1011

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.14471

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27217833

http://www.w3.org/2001/XMLSchema#string

P921

P932

4876624

http://www.w3.org/2001/XMLSchema#string